DTE Analysts Trim Targets as Shorts Quietly Build
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Analysts at four major firms have cut price targets on DTE over the past month. The stock is now trading nearly 17% below the consensus mean target of $156.86. That gap is widening — yet shorts and options markets are beginning to signal something worth watching.
A Wave of Downward Revisions
BMO Capital, Mizuho, and Morgan Stanley all lowered targets in late August. Truist Securities cut its target earlier in the month. None changed their ratings. The street remains constructive — eight buys, consensus at "buy" — but the direction of target revisions is one-way.
Morgan Stanley's David Arcaro trimmed to $148 from $153. Mizuho's Anthony Crowdell went to $152 from $164. BMO's James Thalacker landed at $143. The stock closed Tuesday at $130.70, down 7.2% over the past month.
Next earnings are due October 29.
Shorts Adding Positions Into the Slide
Short interest has risen 14.1% over the past week. It now sits at 2.43% of free float — not extreme in absolute terms, but the pace of accumulation is notable. The move appears to be a fresh bet rather than a squeeze risk. Availability remains extraordinarily wide at 5,866% of short interest. Borrowing costs are just 0.43% annualised. There is no friction here — shorts can enter freely.
The cost to borrow did jump 56% week-on-week. That sounds alarming. But 0.43% is still historically low for any utility name, and the absolute level leaves little room for a lending-driven squeeze.
Options Skew Toward Puts
The put/call ratio hit 0.35 on September 16. That is nearly two standard deviations above the 20-day mean of 0.23. It is not yet at extreme territory — the 52-week high is 1.57 — but the direction is clear. Options traders are hedging or betting against the stock at a pace that stands out versus recent weeks.
The PCR held above 0.35 for two consecutive sessions. That follows a prolonged period through August where it rarely broke above 0.22.
What the Bull Case Says
DTE raised its five-year capex plan to $36.5 billion. Management targets 6%-8% EPS growth. The EPS 12-month forward year-on-year factor ranks at the 82nd percentile. The EPS surprise score sits at the 77th percentile. Those are genuine positives for a regulated utility.
Bears point to FFO-to-debt pressure and Michigan's sluggish data centre pipeline. The initial 2026 EPS guidance disappointed versus prior expectations.
- SI % FF: 2.43%, up 14.1% week-on-week
- Cost to borrow: 0.43%, up 56% week-on-week
- Availability: 5,866% — ample borrow supply
- PCR: 0.35, z-score +1.90 vs 20-day mean
- Consensus target: $156.86 vs close $130.70 (~+20% implied upside)
- Next earnings: October 29
Stocks in this article
See the live data behind this article on ORTEX.
Open DTE on ORTEX →How this article was generated
- Generated
- 17 Sept 2026, 11:11
- Data as of
- 17 Sept 2026, 11:05
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notes
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.